Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Rectal Neoplasms 1Myelodysplastic Syndromes 1Leukemia, Myelomonocytic, Acute 1Leukemia, Myeloid, Acute 1Leukemia, Monocytic, Acute 1Leukemia, Megakaryoblastic, Acute 1Leukemia, Erythroblastic, Acute 1Leukemia, Eosinophilic, Acute 1Leukemia, Basophilic, Acute 1Leukemia 1Congenital Abnormalities 1Colorectal Neoplasms 1Colonic Neoplasms 1Anemia, Refractory, with Excess of Blasts 1

Interventions

Oxaliplatin 7Fluorouracil 6Leucovorin 5Bevacizumab 4Watchful Waiting 3Capecitabine 3XELOX 2Neoadjuvant Therapy 2Irinotecan 2Indocyanine Green 2Chemotherapy, Adjuvant 2Cetuximab 2sulindac sulfone 1pembrolizumab 1encorafenib 1dehydroftorafur 1cyclopropapyrroloindole 1Tranexamic Acid 1Standard of Care 1Sentinel Lymph Node Biopsy 1Radiofrequency Ablation 1Preoperative Exercise 1Positron Emission Tomography Computed Tomography 1Panitumumab 1Observation 1Mental Status and Dementia Tests 1Magnetic Resonance Spectroscopy 1Iohexol 1In Situ Hybridization, Fluorescence 1Immunohistochemistry 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2/3 × Colonic Neoplasms × Cytogenetic Analysis × Clear all
NCT00975897 2013-12-19

Study of Tumor Tissue Testing in Selecting Treatment for Patients With Metastatic or Locally Advanced Colorectal Cancer

National Cancer Institute (NCI)

Phase 2/3 Completed
3,240 enrolled
Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡